These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 6761085)

  • 1. Epidemiology, pathology and clinical features of genital mycoses--1981 status.
    Senft HH; Korte W
    Chemotherapy; 1982; 28 Suppl 1():3-13. PubMed ID: 6761085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
    van Schalkwyk J; Yudin MH;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):266-274. PubMed ID: 26001874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clotrimazole: a review of its antifungal activity and therapeutic efficacy.
    Sawyer PR; Brogden RN; Pinder RM; Speight TM; Avery
    Drugs; 1975; 9(6):424-47. PubMed ID: 1097234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of nystatin G in treatment of vaginal mycosis (author's transl)].
    Konnegen V; Richter P; Blaschke-Hellmessen R
    Zentralbl Gynakol; 1980; 102(1):49-52. PubMed ID: 7193388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society.
    Mendling W; Brasch J; ; ; ;
    Mycoses; 2012 Jul; 55 Suppl 3():1-13. PubMed ID: 22519657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fungal vulvovaginitis.
    Maccato ML; Kaufman RH
    Curr Opin Obstet Gynecol; 1991 Dec; 3(6):849-52. PubMed ID: 1818723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vulvovaginal mycoses. Clinical study of a new antimycotic drug econazole].
    Trossarelli GF; Curti A; Bocci A
    Minerva Ginecol; 1981 May; 33(5):501-6. PubMed ID: 7019769
    [No Abstract]   [Full Text] [Related]  

  • 9. The etiology of pelvic inflammatory disease.
    Keith L; Berger GS
    Res Front Fertil Regul; 1984 May; 3(1):1-16. PubMed ID: 12179634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mycoses in obstetrical and gynecological pathology. The use of miconazole in new preparations in the local therapy of mycotic vaginitis].
    Patrono D; Bonomo A; Painvain E; Di Muccio L
    Minerva Ginecol; 1981 Sep; 33(9):857-62. PubMed ID: 7322430
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sensitivity of Candida albicans and yeast-like fungi to mycostatics in pregnant women].
    Liber Z; Bromboszcz A; Stozek K
    Wiad Lek; 1982 Nov; 35(21):1341-4. PubMed ID: 7164456
    [No Abstract]   [Full Text] [Related]  

  • 12. [The importance of yeast infections and diseases in gynecology and obstetrics].
    Lachenicht P; Siepe EM; Potel J
    Geburtshilfe Frauenheilkd; 1967 Apr; 27(4):352-61. PubMed ID: 5585763
    [No Abstract]   [Full Text] [Related]  

  • 13. Econazole: a review of its antifungal activity and therapeutic efficacy.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1978 Sep; 16(3):177-201. PubMed ID: 98315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do oral contraceptives inhibit Trichomonas vaginalis?
    Bramley M; Kinghorn G
    Sex Transm Dis; 1979; 6(4):261-3. PubMed ID: 316933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k).
    Farr A; Effendy I; Frey Tirri B; Hof H; Mayser P; Petricevic L; Ruhnke M; Schaller M; Schaefer APA; Sustr V; Willinger B; Mendling W
    Mycoses; 2021 Jun; 64(6):583-602. PubMed ID: 33529414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations into the pathoaetiology and diagnosis of vaginal mycoses.
    Schnell JD
    Chemotherapy; 1982; 28 Suppl 1():14-21. PubMed ID: 7160237
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mycoses in the genital area. I. Yeast mycoses].
    Schaller KF
    Mykosen; 1971 Jun; 14(6):303-9. PubMed ID: 5212498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated candidiasis: reinfection or recrudescence? A review.
    Milsom I; Forssman L
    Am J Obstet Gynecol; 1985 Aug; 152(7 Pt 2):956-9. PubMed ID: 4040709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and the prevention of peripartal mycoses.
    Schnell JD
    Chemotherapy; 1982; 28 Suppl 1():66-72. PubMed ID: 7160243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advantages of short-term therapy in vaginal mycoses from a socio-psychological viewpoint].
    Rausch KD; Girardi MR; Korte W
    Fortschr Med; 1982 Mar; 100(10):393-5. PubMed ID: 7068074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.